All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
VOR BIOPHARMA INC. Last Reported: 12/31/2023 Stock Symbol: VOR

Business Address

100 CAMBRIDGEPARK DRIVE
SUITE 101
CAMBRIDGE , MA US 02140

Mailing Address

100 CAMBRIDGEPARK DRIVE
SUITE 101
CAMBRIDGE , MA US 02140
Phone Number: 617-655-6580 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $45,026,000.00 $32,212,000.00 $57,706,000.00 $60,827,000.00 $62,952,000.00 $90,042,000.00 $119,801,000.00 $143,034,000.00 $169,516,000.00 $262,567,000.00 -- $48,539,000.00 -- $63,604,000.00 $72,910,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $164,438,000.00 $191,393,000.00 $236,950,000.00 $142,729,000.00 $158,843,000.00 $190,303,000.00 $214,399,000.00 $232,072,000.00 $249,265,000.00 $266,265,000.00 -- $49,106,000.00 -- -- -- -- --
Property Plant and Equipement $10,824,000.00 $11,458,000.00 $12,634,000.00 $12,963,000.00 $14,832,000.00 $11,767,000.00 $6,853,000.00 $5,990,000.00 $5,852,000.00 $5,737,000.00 -- $4,728,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $4,086,000.00 $3,268,000.00 $2,925,000.00 $2,878,000.00 $2,385,000.00 $8,189,000.00 $3,255,000.00 $2,141,000.00 $2,111,000.00 $2,582,000.00 -- $3,398,000.00 -- -- -- -- --
Total Assets $223,023,000.00 $250,986,000.00 $299,366,000.00 $206,373,000.00 $224,615,000.00 $234,269,000.00 $242,590,000.00 $258,632,000.00 $275,143,000.00 $292,939,000.00 -- $75,908,000.00 -- -- -- -- --
Accounts Payable $1,309,000.00 $1,648,000.00 $1,772,000.00 $824,000.00 $1,268,000.00 $1,255,000.00 $1,545,000.00 $1,957,000.00 $2,369,000.00 $2,406,000.00 -- $2,361,000.00 -- -- -- -- --
Accrued Liabilities $10,274,000.00 $7,256,000.00 $7,889,000.00 $6,288,000.00 $6,286,000.00 $9,258,000.00 $6,335,000.00 $5,676,000.00 $4,293,000.00 $4,395,000.00 -- $6,260,000.00 -- -- -- -- --
Total Current Liabilities $48,242,000.00 $46,536,000.00 $48,759,000.00 $47,639,000.00 $49,641,000.00 $39,822,000.00 $26,327,000.00 $25,675,000.00 $25,035,000.00 $25,752,000.00 -- $27,637,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $488,873,000.00 $485,508,000.00 $473,587,000.00 $358,215,000.00 $350,815,000.00 $348,375,000.00 $346,382,000.00 $344,824,000.00 $343,421,000.00 $342,130,000.00 -- $2,158,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $-280,000.00 $-436,000.00 $-770,000.00 $-1,178,000.00 $-1,326,000.00 $-1,072,000.00 -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-313,819,000.00 $-280,629,000.00 $-222,217,000.00 $-198,307,000.00 $-174,519,000.00 $-152,860,000.00 $-130,123,000.00 $-111,871,000.00 $-93,317,000.00 $-74,947,000.00 -- $-61,224,000.00 -- -- -- -- --
Total Stockholders' Equity $174,781,000.00 $204,450,000.00 $250,607,000.00 $158,734,000.00 $174,974,000.00 $194,447,000.00 $216,263,000.00 $232,957,000.00 $250,108,000.00 $267,187,000.00 -- $-59,065,000.00 -- $-44,142,000.00 $-32,993,000.00 $-25,123,000.00 $-17,429,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $223,023,000.00 $250,986,000.00 $299,366,000.00 $206,373,000.00 $224,615,000.00 $234,269,000.00 $242,590,000.00 $258,632,000.00 $275,143,000.00 $292,939,000.00 -- $75,908,000.00 -- -- -- -- --

Statement of Operations

Date 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 1/31/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $73,418,000.00 $45,812,000.00 $64,550,000.00 $16,875,000.00 $30,613,000.00 $15,280,000.00 $47,529,000.00 $12,925,000.00 $21,911,000.00 $8,941,000.00 -- -- -- $8,142,000.00 $12,146,000.00 $6,171,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $97,912,000.00 $32,174,000.00 $93,418,000.00 $68,693,000.00 $21,792,000.00 $22,800,000.00 $69,018,000.00 $50,712,000.00 $32,110,000.00 $13,730,000.00 -- -- -- $27,703,000.00 $15,918,000.00 $7,878,000.00 --
Loss from Operations $-97,912,000.00 $-62,596,000.00 $-93,418,000.00 $-24,101,000.00 $-44,592,000.00 $-22,800,000.00 $-69,018,000.00 $-50,712,000.00 $-32,110,000.00 $-13,730,000.00 -- -- -- $-27,703,000.00 $-15,918,000.00 $-7,878,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.49 $-0.45 $-2.33 $-0.63 $-0.58 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 66,973,771 67,033,150 39,551,420 38,009,022 37,365,647 -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.37 $-0.88 $-2.33 $-1.81 $-0.58 -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 66,973,771 67,033,150 39,551,420 38,009,022 37,437,063 -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 400,000,000 420,000,000 -- -- -- -- --
Common Stock Shares Outstanding 67,785,469 67,433,560 65,996,138 38,393,211 37,506,236 37,336,314 37,174,741 37,018,282 36,885,372 36,770,010 -- 505,074 -- -- -- -- --
Common Stock Value $7,000.00 $7,000.00 $7,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 -- $1,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- $28.29 -- -- -- --
Copyright 2024 PursePoor.com